Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-26-001709
Filing Date
2026-04-30
Accepted
2026-04-30 16:08:47
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8020
  Complete submission text file 0000929638-26-001709.txt   9801
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Filed by) CIK: 0001583977 (see all company filings)

EIN.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 19 VESTRY STREET NEW YORK NY 10013
Business Address 19 VESTRY STREET NEW YORK NY 10013 6474072515
BRIGHT MINDS BIOSCIENCES INC. (Subject) CIK: 0001827401 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94288 | Film No.: 26925303
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)